MONTREAL, Sept. 9, 2025 /CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), today confirms that it has entered into a binding letter of intent (the "LOI") dated ...
MONTRÉAL, Feb. 26, 2019 /CNW Telbec/ - Oligo Medic announced that Alberto Restrepo has joined the company in the position of Chief Medical Officer to develop medical affairs related to its first ...
A new product called JointRep™ is able to restore lost cartilage in a completely noninvasive operation. The treatment yielded impeccable results in clinical trials on patients aged 18-75 in Europe. It ...
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please ...